Cost-effectiveness of universal HIV testing and treatment: where next?

Jean B. Nachega; Ethan D. Borre; David W. Dowdy; Pascalina Chanda-Kapata; Susan Cleary; Elvin H. Geng

doi:10.1016/S2214-109X(21)00089-9

Cost-effectiveness of universal HIV testing and treatment: where next?

Jean B. Nachega
, Ethan D. Borre
, David W. Dowdy
, Pascalina Chanda-Kapata
, Susan Cleary
, Elvin H. Geng

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	e573-e574
Journal	The Lancet Global Health
Volume	9
Issue number	5
DOIs	https://doi.org/10.1016/S2214-109X(21)00089-9
State	Published - May 2021

Access to Document

10.1016/S2214-109X(21)00089-9

Cite this

@article{b6079a5e3677477a91073ceb1000d214,

title = "Cost-effectiveness of universal HIV testing and treatment: where next?",

author = "Nachega, \{Jean B.\} and Borre, \{Ethan D.\} and Dowdy, \{David W.\} and Pascalina Chanda-Kapata and Susan Cleary and Geng, \{Elvin H.\}",

note = "Funding Information: JBN is supported by the NIH Fogarty International Center ( grant 1R25TW011217–01 , awarded to the African Association for Health Professions Education and Research ; grant 1D43TW010937–01A1 , awarded to the University of Pittsburgh HIV Comorbidities Research Training Program in South Africa; and grant 1R21TW011706-01, awarded to the University of Pittsburgh). All other authors declare no competing interests.",

year = "2021",

month = may,

doi = "10.1016/S2214-109X(21)00089-9",

language = "English",

volume = "9",

pages = "e573--e574",

journal = "The Lancet Global Health",

issn = "2572-116X",

number = "5",

}

TY - JOUR

T1 - Cost-effectiveness of universal HIV testing and treatment

T2 - where next?

AU - Nachega, Jean B.

AU - Borre, Ethan D.

AU - Dowdy, David W.

AU - Chanda-Kapata, Pascalina

AU - Cleary, Susan

AU - Geng, Elvin H.

N1 - Funding Information: JBN is supported by the NIH Fogarty International Center ( grant 1R25TW011217–01 , awarded to the African Association for Health Professions Education and Research ; grant 1D43TW010937–01A1 , awarded to the University of Pittsburgh HIV Comorbidities Research Training Program in South Africa; and grant 1R21TW011706-01, awarded to the University of Pittsburgh). All other authors declare no competing interests.

PY - 2021/5

Y1 - 2021/5

UR - https://www.scopus.com/pages/publications/85104151771

U2 - 10.1016/S2214-109X(21)00089-9

DO - 10.1016/S2214-109X(21)00089-9

M3 - Comment/debate

C2 - 33721567

AN - SCOPUS:85104151771

SN - 2572-116X

VL - 9

SP - e573-e574

JO - The Lancet Global Health

JF - The Lancet Global Health

IS - 5

ER -

Cost-effectiveness of universal HIV testing and treatment: where next?

Access to Document

Other files and links

Cite this